NCT00002351View on ClinicalTrials.gov

A Study of L-735,524 in HIV-Positive Children and Adolescents

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Indinavir sulfate

Trial Locations (1)

088890100

Merck & Co Inc, Whitehouse Station

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00002351 - A Study of L-735,524 in HIV-Positive Children and Adolescents | Biotech Hunter | Biotech Hunter